Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan J Darrow

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
BMJ (Clinical Research Ed.)|June 25, 2020
Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugsJonathan J Darrow, Jessica E Chong, Aaron S Kesselheim
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 18, 2019
Approximating Future Generic Entry for New DrugsReed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Applied Health Economics and Health Policy|August 25, 2018
The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging PatentsJonathan J Darrow, Reed F Beall, Aaron S Kesselheim
Drug Discovery Today|July 29, 2018
Patent term restoration for top-selling drugs in the United StatesReed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Nature Biotechnology|December 9, 2017
Will inter partes review speed US generic drug entry?Jonathan J Darrow, Reed F Beall, Aaron S Kesselheim
JAMA|December 7, 2017
The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016Thomas J Hwang, Jonathan J Darrow, Aaron S Kesselheim
American Journal of Public Health|June 16, 2022
Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent ExclusivitiesRebecca E Wolitz, Aaron S Kesselheim, Jonathan J Darrow
Chest|January 9, 2018
Pharmaceutical Advertising in Medical Journals: Revisiting a Long-Standing RelationshipMichael S Sinha, Aaron S Kesselheim, Jonathan J Darrow
Nature Biotechnology|February 16, 2022
Recent Orange and Purple Book legislation suggests a need to bridge drug and biologic patent regimesBryan S Walsh, Jonathan J Darrow, Aaron S Kesselheim
Journal of General Internal Medicine|April 9, 2021
Changing FDA Approval Standards: Ethical Implications for Patient ConsentJonathan J Darrow, Sanket S Dhruva, Rita F Redberg
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
BMJ (Clinical Research Ed.)|June 25, 2020
Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugsJonathan J Darrow, Jessica E Chong, Aaron S Kesselheim
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|April 18, 2019
Approximating Future Generic Entry for New DrugsReed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Applied Health Economics and Health Policy|August 25, 2018
The Generic Drug Industry Embraces a Faster, Cheaper Pathway for Challenging PatentsJonathan J Darrow, Reed F Beall, Aaron S Kesselheim
Drug Discovery Today|July 29, 2018
Patent term restoration for top-selling drugs in the United StatesReed F Beall, Jonathan J Darrow, Aaron S Kesselheim
Nature Biotechnology|December 9, 2017
Will inter partes review speed US generic drug entry?Jonathan J Darrow, Reed F Beall, Aaron S Kesselheim
JAMA|December 7, 2017
The FDA's Expedited Programs and Clinical Development Times for Novel Therapeutics, 2012-2016Thomas J Hwang, Jonathan J Darrow, Aaron S Kesselheim
American Journal of Public Health|June 16, 2022
Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent ExclusivitiesRebecca E Wolitz, Aaron S Kesselheim, Jonathan J Darrow
Chest|January 9, 2018
Pharmaceutical Advertising in Medical Journals: Revisiting a Long-Standing RelationshipMichael S Sinha, Aaron S Kesselheim, Jonathan J Darrow
Nature Biotechnology|February 16, 2022
Recent Orange and Purple Book legislation suggests a need to bridge drug and biologic patent regimesBryan S Walsh, Jonathan J Darrow, Aaron S Kesselheim
Journal of General Internal Medicine|April 9, 2021
Changing FDA Approval Standards: Ethical Implications for Patient ConsentJonathan J Darrow, Sanket S Dhruva, Rita F Redberg
Pageof 9